Harnessing autophagy: A potential breakthrough in digestive disease treatment


Eşrefoğlu M.

WORLD JOURNAL OF GASTROENTEROLOGY, cilt.30, sa.24, ss.3036-3043, 2024 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 30 Sayı: 24
  • Basım Tarihi: 2024
  • Doi Numarası: 10.3748/wjg.v30.i24.3036
  • Dergi Adı: WORLD JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.3036-3043
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Autophagy, a conserved cellular degradation process, is crucial for various

cellular processes such as immune responses, inflammation, metabolic and

oxidative stress adaptation, cell proliferation, development, and tissue repair and

remodeling. Dysregulation of autophagy is suspected in numerous diseases,

including cancer, neurodegenerative diseases, digestive disorders, metabolic

syndromes, and infectious and inflammatory diseases. If autophagy is disrupted,

for example, this can have serious consequences and lead to chronic inflammation

and tissue damage, as occurs in diseases such as Chron's disease and ulcerative

colitis. On the other hand, the influence of autophagy on the development and

progression of cancer is not clear. Autophagy can both suppress and promote the

progression and metastasis of cancer at various stages. From inflammatory bowel

diseases to gastrointestinal cancer, researchers are discovering the intricate role of

autophagy in maintaining gut health and its potential as a therapeutic target.

Researchers should carefully consider the nature and progression of diseases such

as cancer when trying to determine whether inhibiting or stimulating autophagy

is likely to be beneficial. Multidisciplinary approaches that combine cutting-edge

research with clinical expertise are key to unlocking the full therapeutic potential

of autophagy in digestive diseases